Aptamer Group is holding its AGM today in York, where the Chairman will outline continued commercial progress, recent contract wins with major pharmaceutical companies, and an FY26 order book of £1.95 million...
AstraZeneca has received US approval for Imfinzi combined with FLOT chemotherapy for adults with resectable early-stage and locally advanced gastric and gastroesophageal junction cancers...
Strix Group has issued a trading update confirming stable revenue, early signs of recovery in its Controls division, continued strong performance from Billi, and renewed growth in Consumer Goods...
Avation will hold its AGM in Singapore today, where the Chairman will outline steady fleet activity, stable lease income, ongoing aircraft placements, and a stronger financial position following recent refinancing...
Cerillion’s Louis Hall breaks down a record year of performance, including a major new market entry in Armenia and a £25m expansion in Europe. With a robust order pipeline and shrinking competition, Cerillion is well-positioned to build on its momentum heading into FY26...
NB Private Equity Partners: Analyst Mark Thomas explains how rising exits, midlife co-investments and accelerated buybacks suggest NBPE is on track for a rebound. Could the second half of 2025 be the turning point investors have been waiting for?..
Outages at AWS and Cloudflare aren’t just inconvenient — they’re a wake-up call. Verge Technologies CEO Jimmy Jobe explains how SentientDB keeps databases globally available, with zero downtime and full automation...
Jason Streets of Hardman & Co explains why Cavendish Plc’s strong cash position and consistent earnings make it one of the UK’s most resilient small-cap investment banks — even as M&A volumes slide...
Phoenix Group says the PRA’s LIST 2025 results confirm a solid capital position, with all metrics remaining within its 140 to 180% shareholder capital coverage target range...
AstraZeneca has confirmed a $2 billion investment to expand its manufacturing presence in Maryland, including a larger biologics facility in Frederick and a new clinical manufacturing site in Gaithersburg...
Cerillion has delivered record results for the year to 30 September 2025, with revenue, earnings and cash increasing. New orders rose 25% to £47.6m and the back order book reached £56.9m...
Aptamer Group is holding its AGM today in York, where the Chairman will outline continued commercial progress, recent contract wins with major pharmaceutical companies, and an FY26 order book of £1.95 million...
AstraZeneca has received US approval for Imfinzi combined with FLOT chemotherapy for adults with resectable early-stage and locally advanced gastric and gastroesophageal junction cancers...
Strix Group has issued a trading update confirming stable revenue, early signs of recovery in its Controls division, continued strong performance from Billi, and renewed growth in Consumer Goods...
Avation will hold its AGM in Singapore today, where the Chairman will outline steady fleet activity, stable lease income, ongoing aircraft placements, and a stronger financial position following recent refinancing...
Cerillion’s Louis Hall breaks down a record year of performance, including a major new market entry in Armenia and a £25m expansion in Europe. With a robust order pipeline and shrinking competition, Cerillion is well-positioned to build on its momentum heading into FY26...
NB Private Equity Partners: Analyst Mark Thomas explains how rising exits, midlife co-investments and accelerated buybacks suggest NBPE is on track for a rebound. Could the second half of 2025 be the turning point investors have been waiting for?..
Outages at AWS and Cloudflare aren’t just inconvenient — they’re a wake-up call. Verge Technologies CEO Jimmy Jobe explains how SentientDB keeps databases globally available, with zero downtime and full automation...
Jason Streets of Hardman & Co explains why Cavendish Plc’s strong cash position and consistent earnings make it one of the UK’s most resilient small-cap investment banks — even as M&A volumes slide...
Phoenix Group says the PRA’s LIST 2025 results confirm a solid capital position, with all metrics remaining within its 140 to 180% shareholder capital coverage target range...
AstraZeneca has confirmed a $2 billion investment to expand its manufacturing presence in Maryland, including a larger biologics facility in Frederick and a new clinical manufacturing site in Gaithersburg...
Cerillion has delivered record results for the year to 30 September 2025, with revenue, earnings and cash increasing. New orders rose 25% to £47.6m and the back order book reached £56.9m...
